PIN30 USE OF NET-BENEFIT REGRESSION FRAMEWORK TO INVESTIGATE THE COST-EFFECTIVENESS OF COMBINATION ANTIVIRAL THERAPY AMONG HCV-INFECTED PATIENTS ENROLLED IN A MANAGED CARE ORGANIZATION
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75088-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)75088-9/fulltext
Title :
PIN30 USE OF NET-BENEFIT REGRESSION FRAMEWORK TO INVESTIGATE THE COST-EFFECTIVENESS OF COMBINATION ANTIVIRAL THERAPY AMONG HCV-INFECTED PATIENTS ENROLLED IN A MANAGED CARE ORGANIZATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75088-9&doi=10.1016/S1098-3015(10)75088-9
First page :
Section Title :
Open access? :
No
Section Order :
1013